전체 프로그램

CGTBiologicstaleBeacon TherapeuticsPhase 2

rAAV2tYF-PR1.7-hCNGB3 (rAAV2tYF-PR1.7-hCNGB3)

Achromatopsia · Achromatopsia

#Achromatopsia#CGT#Phase2#세포유전치료#CAR-T+2

CGTBiologicstaleEunice Kennedy Shriver National…Phase 1

recombinant adenovirus containing the ornithine transcarbamylase gene (recombinant adenovirus containing the ornithine transcarbamylase gene)

Ornithine Transcarbamylase Deficiency Disease · Ornithine Transcarbamylase Deficiency Di

#OrnithineTranscarbamylaseDeficie#CGT#Phase1#세포유전치료#CAR-T+2

AntibodystaleRochePhase 3

recombinant human thrombopoietin (rhTPO, recombinant human thrombopoietin, recombinant human thrombopoietin (rhTPO); rituximab)

Purpura; Idiopathic Thrombocytopenic Purpura · Purpura

#Purpura#Antibody#Phase3#항체#면역항체+3

AntibodystaleThe Affiliated Hospital of Qing…Phase 1

HS627 (recombinant monoclonal antibody against human epidermal growth factor receptor injection, recombinant monoclonal antibody against human epidermal growth factor receptor injection (HS627))

Healthy Volunteers · Healthy Volunteers

#HealthyVolunteers#Antibody#Phase1#항체#면역항체+2

AntibodystaleDan LiangPhase 2

adalimumab (Humira, reduction or discontinuation of Adalimumab)

Uveitis; Adalimumab · Uveitis

#Uveitis#Antibody#Phase2#항체#면역항체+3

AntibodystaleUniversity of UtahPhase 1

regorafenib + panitumumab (regorafenib + panitumumab)

KRAS and NRAS Wild-type Colorectal Cancer · KRAS and NRAS Wild-type Colorectal Cance

#KRASandNRASWild-typeColorectalCa#Antibody#Phase1#항체#면역항체+2

AntibodystaleBristol Myers SquibbPhase 2

nivolumab (Opdivo, relatlimab+nivolumab)

Melanoma · Melanoma

#Melanoma#Antibody#Phase2#항체#면역항체+2

효능 ORR 44.4%임상시험 1상태 ACTIVE

AntibodystaleBristol Myers SquibbPhase 2

nivolumab (Opdivo, relatlimab+nivolumab+rHuPH20)

Melanoma · Melanoma

#Melanoma#Antibody#Phase2#항체#면역항체+2

AntibodystaleJanssenPreclinical

response to infliximab associated with methotrexate (response to infliximab associated with methotrexate)

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Preclinical#항체#면역항체+2

AntibodystaleGenentech, Inc.Phase 3

ranibizumab (rhuFab V2, rhuFab V2 (ranibizumab))

Macular Degeneration · Macular Degeneration

#MacularDegeneration#Antibody#Phase3#항체#면역항체+2

효능 ORR 56.4%임상시험 1상태 ACTIVE

AntibodystaleRochePhase 3

Bevacizumab (rhuMAb VEGF, rhuMAb VEGF (Bevacizumab))

Renal Cell Cancer · Renal Cell Cancer

#RenalCellCancer#Antibody#Phase3#항체#면역항체+2

ADCBiologicstaleMerck Sharp & Dohme LLCPhase 3

sac-TMT (sac-TMT)

Non-small Cell Lung Cancer; NSCLC · Non-small Cell Lung Cancer

#Non-smallCellLungCancer#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+2

CGTBiologicstaleNationwide Children's HospitalPhase 2

scAAV1.tMCK.NTF3 (scAAV1.tMCK.NTF3)

Charcot-Marie-Tooth Neuropathy Type 1A · Charcot-Marie-Tooth Neuropathy Type 1A

#Charcot-Marie-ToothNeuropathyTyp#CGT#Phase2#세포유전치료#CAR-T+2

CGTBiologicstaleUltragenyx Pharmaceutical IncPhase 2

scAAV8OTC (scAAV8OTC)

Ornithine Transcarbamylase (OTC) Deficiency · Ornithine Transcarbamylase (OTC) Deficie

#OrnithineTranscarbamylaseOTCDefi#CGT#Phase2#세포유전치료#CAR-T+2

CGTBiologicstaleUniversity of Texas Southwester…Phase 1

scAAV9/JeT-GAN (scAAV9/JeT-GAN)

Giant Axonal Neuropathy (GAN) · Giant Axonal Neuropathy (GAN)

#GiantAxonalNeuropathyGAN#CGT#Phase1#세포유전치료#CAR-T+2

AntibodystaleRochePhase 3

serplulimab、bevacizumab (serplulimab、bevacizumab)

Rectal Cancer · Rectal Cancer

#RectalCancer#Antibody#Phase3#항체#면역항체+2

CGTBiologicstaleThe First Affiliated Hospital o…Phase 2

ssCART-19 cells combined with CD19+ feeding T cells (FTCs, ssCART-19 cells combined with CD19+ feeding T cells, ssCART-19 cells combined with CD19+ feeding T cells (FTCs) infusion)

Acute Lymphoblastic Leukemia, Adult B-Cell · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+4

AntibodystaleUniversity Hospital, Gentofte, …Preclinical

adalimumab (Humira, subjects will receive either infliximab, adalimumab or etanercept)

Psoriasis · Psoriasis

#Psoriasis#Antibody#Preclinical#항체#면역항체+2

CGTBiologicstaleUniversity College, LondonPhase 2

rAAV 2/2.hRPE65p.hRPE65 (tgAAG76, tgAAG76 (rAAV 2/2.hRPE65p.hRPE65))

Retinal Degeneration · Retinal Degeneration

#RetinalDegeneration#CGT#Phase2#세포유전치료#CAR-T+2